Mackenzie Financial
DPLO

Mackenzie Financial’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mackenzie Financial’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-51,800
Closed -$653K – 725
2016
Q4 		$653K Hold
51,800
– – ﹤0.01% 487
2016
Q3 		$1.45M Buy
+51,800
New +$1.74M 0.01% 370

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mackenzie Financial's DPLO Position: Q1 2017 in Review

Mackenzie Financial sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 51,800 shares — an estimated $653K sold.

Mackenzie Financial first reported a position in DPLO in Q3 2016 and held it in 2 quarters. The position peaked at $1.45M in Q3 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Mackenzie Financial reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Mackenzie Financial sold 51,800 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $653K.
  • Mackenzie Financial first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 2 quarters.
  • Mackenzie Financial's DIPLOMAT PHARMACY, INC. position peaked at $1.45M in Q3 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Mackenzie Financial's 13F filing for Q1 2017, filed 12 May 2017.